Thermo Fisher Scientific | TMO - Marktkapitalisierung

Aktienkurs
526.60
Täglich Wechseln
10.60 2.05%
Monatlich
13.32%
Jährlich
22.47%
Q2 Prognose
515.01




Marktkapitalisierung Veränderung Datum
Abbott USD 165.59B 12.82B 2026-04
Agilent USD 37.86B 3.64B 2025-12
Becton, Dickinson and Co. USD 55.29B 1.64B 2025-12
Bio Techne USD 9.16B 502M 2025-12
Bio-Rad Laboratories USD 8.21B 601M 2025-12
Boston Scientific USD 141.35B 3.31B 2025-12
Bruker USD 7.16B 2.23B 2025-12
Charles River Laboratories USD 10.02B 2.71B 2025-12
Danaher USD 161.7B 29.34B 2025-12
Dentsply International USD 2.28B 251M 2025-12
Edwards Lifesciences USD 49.47B 3.81B 2025-12
General Electric Aerospace USD 324.91B 5.91B 2025-12
Henry Schein USD 8.96B 951M 2025-12
Illumina USD 20.62B 6.53B 2025-12
Intuitive Surgical USD 200.77B 40.45B 2025-12
IQVIA Holdings USD 38.39B 6.1B 2025-12
Laboratory Of America USD 20.8B 3.03B 2025-12
Mettler Toledo International USD 28.48B 3.19B 2025-12
Myriad Genetics USD 575M 98M 2025-12
Olympus JPY 2.21T 80.41B 2025-12
OraSure Technologies USD 174M 61M 2025-12
Quest Diagnostics USD 19.3B 2.01B 2025-12
Repligen USD 9.22B 1.7B 2025-12
Revvity USD 10.97B 1.21B 2025-12
Stryker USD 134.41B 6.92B 2025-12
Thermo Fisher Scientific USD 217.7B 42.4B 2025-12
Veracyte USD 3.33B 627M 2025-12
Waters USD 22.61B 5.25B 2025-12
Zimmer Biomet Holdings USD 17.82B 1.69B 2025-12